Global Mouse Model Services Market Size By Type (Outbred, Inbred), By Application (Academic And Research Institutes, Pharmaceutical And Biotechnology Companies), By Region, And Segment Forecasts, 2023...

The Global Mouse Model Services Market was valued at USD 1.6 billion in 2023 and is projected to surpass USD 3.1 billion by 2031, expanding at a compound annual growth rate (CAGR) of 8.7% during the forecast period from 2023 to 2031. The market's growth is primarily fueled by the rising demand for preclinical research, increasing focus on personalized medicine, and the widespread application of mouse models in drug development and disease studies. As pharmaceutical and biotechnology companies accelerate their R&D investments, the adoption of genetically engineered and humanized mouse models is surging, enhancing the relevance and translational value of preclinical data.

Drivers

1. Rising R&D Investment in Pharmaceutical and Biotechnology Industries:

Pharmaceutical companies are increasingly relying on mouse model services to evaluate drug efficacy, toxicity, and disease mechanisms. The growing need for early-phase preclinical validation is boosting demand for custom and off-the-shelf mouse models.

2. Technological Advancements in Genetic Engineering:

Recent innovations, including CRISPR-Cas9 gene editing and next-generation sequencing, have revolutionized the generation of complex mouse models. These advancements enable the creation of highly specific models that closely mimic human diseases.

3. Growing Demand for Personalized Medicine:

As precision medicine gains traction, the need for patient-derived xenograft (PDX) and humanized mouse models has escalated. These models offer improved predictive validity for therapeutic responses, especially in oncology and immunology.

Restraints

1. Ethical and Regulatory Concerns:

Strict regulations regarding animal testing and the ethical implications of animal use in research can hinder the growth of mouse model services, particularly in regions with stringent animal welfare laws.

2. High Cost and Time-Intensive Development:

Developing custom genetically engineered models is often costly and time-consuming, which can limit accessibility for smaller research organizations and academic institutions.

Opportunity

1. Expansion in Emerging Markets and Academic Collaborations:

Growing investments in life sciences across Asia-Pacific and Latin America are creating lucrative opportunities. Additionally, academic-industry partnerships are enhancing access to sophisticated mouse models.

2. Integration with AI and Data Analytics:

Advanced computational tools are improving the design, monitoring, and data interpretation of mouse model studies, enabling faster and more accurate results. Integration with AI will play a pivotal role in the next-generation mouse model ecosystem.

Market by System Type Insights

Based on system type, the Genetically Engineered Mouse Models (GEMMs) segment held the largest market share in 2023. GEMMs are extensively used to study gene function and model complex human diseases such as cancer and neurodegenerative disorders. The Humanized Mouse Models segment is expected to grow at the fastest rate, driven by their increasing utility in immunotherapy and infectious disease research.

Market by End-use Insights

The Pharmaceutical & Biotechnology Companies segment emerged as the dominant end-user in 2023, contributing over 50% of the market share. This is attributed to the increasing volume of preclinical drug screening. The Academic & Research Institutions segment is anticipated to expand steadily due to rising public research funding and collaborative translational studies.

Market by Regional Insights

North America led the global mouse model services market in 2023, driven by advanced biomedical research infrastructure, strong funding for life sciences, and the presence of leading CROs and biotech firms. Asia-Pacific is expected to witness the highest CAGR during the forecast period, supported by growing R&D activities, rising healthcare expenditure, and favorable government initiatives in countries like China, Japan, and India.

Competitive Scenario

Prominent players in the Global Mouse Model Services Market include Charles River Laboratories, The Jackson Laboratory, Taconic Biosciences, genOway, Envigo, Trans Genic Inc., Crown Bioscience, InVivo Biosystems, and Cyagen Biosciences. These companies are focusing on geographic expansion, strategic acquisitions, and development of novel mouse model platforms.

Recent Developments:

In 2023, Charles River Laboratories expanded its humanized mouse model portfolio to support oncology and virology drug development.

Taconic Biosciences announced a partnership in 2024 to co-develop next-gen microbiome-relevant mouse models.

In 2025, The Jackson Laboratory launched an AI-powered tool to optimize mouse model selection for preclinical studies.

Scope of Work – Global Mouse Model Services Market

Key Market Developments

2023: Charles River Laboratories expanded their CRISPR-engineered humanized mouse model offerings for immuno-oncology research.

2024: Taconic Biosciences announced a collaboration with a biotech firm to develop mouse models with microbiota specificity.

2025: InVivo Biosystems introduced an AI-driven phenotyping platform for real-time mouse model analysis in gene therapy studies.

FAQs

1) What is the current market size of the Global Mouse Model Services Market?

The market size in 2023 is USD 1.6 billion.

2) What is the major growth driver of the Global Mouse Model Services Market?

The primary growth driver is the increasing R&D investment in pharmaceutical and biotechnology industries.

3) Which is the largest region during the forecast period in the Global Mouse Model Services Market?

North America is the largest region, driven by advanced biomedical infrastructure and strong life sciences funding.

4) Which segment accounted for the largest market share in the Global Mouse Model Services Market?

The Genetically Engineered Mouse Models (GEMMs) segment accounted for the largest share in 2023.

5) Who are the key market players in the Global Mouse Model Services Market?

Key players include Charles River Laboratories, The Jackson Laboratory, Taconic Biosciences, genOway, and Cyagen Biosciences.